rs1173771 — NPR3 NPR3 promoter variant

Regulatory variant near the NPR3 transcription start site that reduces natriuretic peptide clearance receptor expression in vascular smooth muscle and endothelial cells, raising blood pressure by impairing ANP and BNP removal from circulation

See your personal result for NPR3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

NPR3 — The Clearance Valve That Sets Your Blood Pressure

Your blood pressure is governed in part by a family of hormones called natriuretic peptides11 natriuretic peptides
ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) — released by heart muscle cells in response to stretch when blood volume rises. These peptides act on blood vessel walls and kidneys to promote vasodilation and sodium excretion, pulling blood pressure back down. But natriuretic peptides need a mechanism to be cleared from the bloodstream — otherwise their blood-pressure-lowering signal would never switch off.

That clearance role belongs to NPR3, the natriuretic peptide receptor C gene. NPR3 encodes a decoy receptor on vascular smooth muscle and endothelial cells that binds ANP and BNP and internalizes them for degradation — functioning as a physiological "off switch" for natriuretic peptide signaling. When NPR3 is highly expressed, natriuretic peptides are cleared rapidly, reducing their protective vasodilatory signal. When NPR3 is lower, peptides linger in circulation longer, sustaining blood pressure reduction.

The variant rs1173771 sits near the NPR3 transcription start site22 transcription start site
the region of DNA from which gene expression is initiated and reached genome-wide significance for systolic blood pressure, diastolic blood pressure, pulse pressure, and hypertension in the ICBP meta-analysis33 ICBP meta-analysis
International Consortium for Blood Pressure, combining data from ~200,000 individuals of European descent. The G allele is the BP-elevating allele.

The Mechanism

Functional studies show that the BP-elevating haplotype tagged by rs1173771 is associated with lower endogenous NPR3 mRNA and protein in vascular smooth muscle cells (VSMCs)44 lower endogenous NPR3 mRNA and protein in vascular smooth muscle cells (VSMCs)
detected in primary human VSMCs from carriers of the BP-elevating allele vs. the protective allele, along with reduced open chromatin and nuclear protein binding at the locus. In other words, the G allele reduces NPR3 expression — but paradoxically, lower NPR3 means less clearance of vasodilatory natriuretic peptides. The key is that the downstream consequences go beyond simple clearance.

Lower NPR3 expression in VSMCs produces three compounding effects: increased cell proliferation55 increased cell proliferation
partially reversible by natriuretic peptide treatment, linking genotype to atherogenic smooth muscle behavior, enhanced angiotensin II-induced intracellular calcium flux66 angiotensin II-induced intracellular calcium flux
a molecular signature of heightened vasoconstriction responsiveness, and increased VSMC contraction. The net result is a vascular phenotype primed for higher resting blood pressure and greater pressor responses.

A 2024 experimental model using Dahl salt-sensitive rats77 2024 experimental model using Dahl salt-sensitive rats
Dahl SS rats are a classic model of salt-sensitive hypertension reinforced this picture: when researchers deleted the orthologous noncoding haplotype region, NPR3 was upregulated in arteries and salt-induced systolic blood pressure rose by approximately 10 mmHg less than in unedited controls. The 2025 renal chromatin study88 2025 renal chromatin study
Mapping of ATAC-seq accessible chromatin in human proximal tubule and medullary thick ascending limb segments found rs1173771 enriched within regulatory chromatin in kidney segments that control sodium-water balance, extending the relevant tissue context from vessels to kidney.

The Evidence

The core blood pressure association is established and multiply replicated99 established and multiply replicated
GWAS Catalog accessions GCST001227, GCST001228, GCST001235, GCST001236, GCST001238. In the original ICBP meta-analysis, the G allele reached P=2×10⁻¹⁶ for systolic BP (beta +0.50 mmHg per allele) and P=9×10⁻¹² for diastolic BP (beta +0.26 mmHg), P=3×10⁻¹⁰ for hypertension (OR 1.06 per allele).

The effect is small per allele but has been replicated transethnic across European and East Asian populations. A 2013 transethnic meta-analysis1010 2013 transethnic meta-analysis
East Asian stage 1 n=26,600, stage 2 up to 28,783 participants confirmed rs1173771 shows suggestive replication (P=0.018) for mean arterial pressure with consistent effect direction across ancestries. The Genetics of Postural Hemodynamics (GPH) Consortium study1111 Genetics of Postural Hemodynamics (GPH) Consortium study
Published Eur Heart J 2012 found that the A allele was modestly protective against orthostatic hypotension (OR 0.92, 95% CI 0.87–0.98, P=0.009), consistent with the G allele being the BP-elevating variant.

The functional work by Ren et al. (2018) bridges the statistical association to mechanism: using primary human VSMCs genotyped at rs1173771, they demonstrated allele-specific differences in NPR3 expression and downstream vascular cell behavior, elevating this from a statistical GWAS hit to a biologically understood variant.

Practical Actions

The per-allele blood pressure effect (~0.5 mmHg SBP per G allele) is modest in isolation. GG homozygotes carry the full additive effect (~1 mmHg SBP higher than AA), which over a lifetime can compound with other risk factors. The critical question is whether blood pressure lands in the normal, elevated, or hypertensive range in the context of your full genetic and lifestyle profile.

The most important practical implication is monitoring: home blood pressure measurement provides personalized data that genetic risk estimates cannot. If blood pressure trends upward — even into the high-normal range (120–129/80 mmHg) — early lifestyle and dietary intervention is more effective than waiting for overt hypertension to develop.

Dietary sodium is particularly relevant: the NPR3 pathway is central to sodium excretion and fluid balance. Excess dietary sodium blunts natriuretic peptide effectiveness, compounding the reduced clearance capacity created by lower NPR3 expression.

Interactions

rs1173771 is part of a 17.4 kb haplotype block at the NPR3 locus containing 11 SNPs. The sentinel variant rs1173771 tags this haplotype, and the entire block functions as a regulatory unit. Other SNPs in the NPR3 gene region — including rs22709151212 rs2270915
a previously studied NPR3 promoter polymorphism associated with blood pressure in type 2 diabetes — may have partially overlapping or independent effects. Other blood-pressure GWAS loci in the natriuretic peptide pathway include NPPA/NPPB (ANP and BNP precursor genes) and NPPB itself; collectively, variation across the natriuretic peptide system accumulates to influence resting blood pressure trajectory.

Genotype Interpretations

What each possible genotype means for this variant.

AA Normal NPR3 Expression Normal

Standard natriuretic peptide clearance — typical blood pressure trajectory from this locus

You carry two copies of the A allele at rs1173771, associated with normal NPR3 expression in vascular smooth muscle and endothelial cells. This means your natriuretic peptide clearance system operates at its typical capacity, with no genetically increased risk of elevated blood pressure from this locus. About 15% of people globally share this genotype. Blood pressure is still influenced by many other genetic and lifestyle factors.

AG Mildly Elevated NPR3 Risk Intermediate

One copy of the BP-elevating allele — mildly increased blood pressure risk

The G allele at rs1173771 is associated with reduced NPR3 expression in vascular smooth muscle cells (VSMCs), which alters VSMC behavior — increasing proliferation and angiotensin II-mediated contraction responses. The net result is a vascular tone that trends slightly higher. The GWAS-derived effect size (beta +0.50 mmHg SBP per G allele) is small, but blood pressure is polygenic: accumulating effects across many loci collectively shape lifetime hypertension risk. Home blood pressure monitoring provides a direct, individualized readout that integrates all these genetic contributions.

Dietary sodium is particularly relevant to the NPR3 pathway: natriuretic peptides are released in response to volume expansion from high sodium intake, and their clearance determines how effectively the system resets. Dietary strategies that reduce sodium load work synergistically with your natriuretic peptide system.

GG Highest NPR3 Locus Risk High Risk

Two copies of the BP-elevating allele — maximal additive effect on blood pressure from this locus

As a GG homozygote, both copies of your NPR3 regulatory region carry the BP-elevating haplotype. Functional studies show this genotype is associated with the lowest NPR3 mRNA and protein expression in VSMCs, the greatest increase in angiotensin II-induced calcium flux, and the most pronounced VSMC proliferation and contraction responses. This creates a vascular smooth muscle environment that is persistently primed for higher tone.

The NPR3 clearance pathway is a key node connecting your kidneys' sodium handling to arterial resistance. Excess dietary sodium overwhelms natriuretic peptide secretion; with reduced NPR3 clearance capacity, the counterregulatory signal is already partially blunted, making salt sensitivity a particularly relevant concern for GG carriers.

GWAS data show the G allele also associates with blood pressure in East Asian and transethnic populations, suggesting this is a broadly relevant variant, not a population-specific effect. The hypertension OR for GG vs AA is approximately 1.12 (two-allele additive model from the single-allele OR 1.06), consistent with a meaningful lifetime contribution to hypertension risk.